P-glycoprotein inhibition promotes prednisone retention in human sinonasal polyp explants

International Forum of Allergy and Rhinology

Volumn 4, Issue 9, 2014, Pages 734-738

  Kocharyan, Armine ^a   Feldman, Rachel ^a   Singleton, Amy ^b   Han, Xue ^b   Bleier, Benjamin S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Boston University   (United States)

Author keywords

ATP dependent efflux pumps; Chronic sinusitis; Corticosteroids; Nasal polyposis; P glycoprotein, MDR1; Prednisone; Steroid resistance

Indexed keywords

ANTIINFLAMMATORY AGENT; DIBENZO[A,D]CYCLOHEPTENE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN; PREDNISONE; QUINOLINE DERIVATIVE; VERAPAMIL; ZOSUQUIDAR;

ANTAGONISTS AND INHIBITORS; CYTOPLASM; HUMAN; METABOLISM; NOSE POLYP;

ANTI-INFLAMMATORY AGENTS; CYTOPLASM; DIBENZOCYCLOHEPTENES; HUMANS; NASAL POLYPS; P-GLYCOPROTEIN; PREDNISONE; QUINOLINES; VERAPAMIL;

EID: 84906841258     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21361     Document Type: Article

References (21)

1. Bleier BS. Regional expression of epithelial MDR1/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis. Int Forum Allergy Rhinol. 2012;2:122-125.
2. Maier A, Zimmermann C, Beglinger C, Drewe J, Gutmann H. Effects of budesonide on P-glycoprotein expression in intestinal cell lines. Br J Pharmacol. 2007;150:361-368.
3. Henriksson G, Norlander T, Zheng X, Stierna P, Westrin KM. Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids. Am J Rhinol. 1997;11:317-321.
4. Feldman RE, Lam AC, Sadow PM, Bleier BS. P-glycoprotein is a marker of tissue eosinophilia and radiographic inflammation in chronic rhinosinusitis without nasal polyps. Int Forum Allergy Rhinol. 2013;3:684-687.
5. Bleier BS, Nocera AL, Iqbal H, Hoang JD, Feldman RE, Han X. P-glycoprotein functions as an immunomodulator in healthy human primary nasal epithelial cells. Int Forum Allergy Rhinol. 2013;3:433-438.
6. Narang VS, Fraga C, Kumar N, et al. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol. 2008;295:C440-C450.
7. Demeule M, Jodoin J, Beaulieu E, Brossard M, Béliveau R. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett. 1999;442:208-214.
8. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;(23):3 p preceding table of contents, 1-298.
9. Kirkeby S, Thomsen CE. Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software. J Immunol Methods. 2005;301:102-113.
10. Fernandez C, Buyse M, German-Fattal M, Gimenez F. Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J Pharm Pharm Sci. 2004;7:359-371.
11. Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992;258:1650-1654.
12. Barnes KM, Dickstein B, Cutler GB, Fojo T, Bates SE. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry. 1996;35:4820-4827.
13. Ueda K, Okamura N, Hirai M, et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem. 1992;267:24248-24252.
14. Webster JI, Carlstedt-Duke J. Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response. J Steroid Biochem Mol Biol. 2002;82:277-288.
15. Mares-Sámano S, Badhan R, Penny J. Identification of putative steroid-binding sites in human ABCB1 and ABCG2. Eur J Med Chem. 2009;44:3601-3611.
16. Farrell RJ, Murphy A, Long A, et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 2000;118:279-288.
17. Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet. 2003;42:59-98.
18. Funaki S, Takahashi S, Wada N, Murakami H, Harada K. Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome. Pediatr Int. 2008;50:159-161.
19. Kooij G, Backer R, Koning JJ, et al. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One. 2009;4:e8212.
20. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294:1866-1870.
21. Bertilsson G, Heidrich J, Svensson K, et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A. 1998;95:12208-12213.